Controlling the number of lymphocytes and their activation status are keys in the prevention of autoimmunity. Known molecular factors that contribute to prevention of autoimmune phenomena include antigen-presenting cell (APC)-T-cell interactions (stimulating activation induced apoptosis), as well as an array of death receptors and inhibitory molecules. Until very recently, receptor protein tyrosine kinases (rPTKs)-cell surface enzymes capable of engaging cytoplasmic signaling cascades-were not found on lists of proteins playing immune regulatory roles. Tyro 3, Axl, and Mer are closely related rPTKs that make up the Tyro 3 family. They are widely expressed, but importantly, are not found in B or T lymphocytes. Previous work implicated these receptors in spermatogonial and neural development (see Additional information [1] ), as well as in clearance of apoptotic cells (see Additional information [2]). The aim of the current study was to characterize the immune cell phenotype of animals made triply deficient in Tyro 3, Axl, and Mer.
Significant findings
Tyro 3-, Axl-, and Mer-deficient (TAM -/-) animals exhibit a number of classic autoimmune features. Their massively enlarged spleens and lymph nodes contain expanded numbers of inappropriately activated B cells and T cells. Additionally, nonlymphoid tissues from TAM -/mice contain focal collections of lymphocytes. The TAM -/mice have arthritis and elevated titers of anti-dsDNA and antiphospholipid autoantibodies.
Autoimmunity in the TAM -/mice is attributable to primary myeloid, rather than lymphoid hyperactivity. Tyro 3, Axl, or Mer transcripts are present exclusively in myeloid-enriched, nonlymphoid areas of the spleen (red pulp and marginal zones) and thymus (central medulla). Further, resting wild-type lymphocytes proliferate spontaneously when transferred into TAM -/-, but not wild-type hosts. Finally, splenic TAM -/macrophages have an activated surface phenotype, hypersecrete IL-12, and show enhanced phagocytosis and responses to lipopolysaccharides in vitro.
Comments
Strikingly, anti-dsDNA and antiphospholipid antibodies in the TAM -/mice correlate with the presence of pregnancy losses and cerebral hemorrhages, prompting comparison of the phenotype with the human antiphospholipid antibody syndrome. The findings support the notion that lymphoid hyperactivation in TAM -/mice is not a primary defect. Rather, loss of Tyro 3, Axl, and Mer causes APC hyperactivity, with secondary lymphoid activation.
The TAM -/mice establish a novel immune-inhibitory signaling axis, and highlight the importance of suppressing APC activation in the containment of autoimmunity. Future pathogenetic investigations into disease states such as systemic lupus and the antiphospholipid antibody syndrome may reveal abnormalities in the signaling events dependent upon these rPTKs.
